Oxford Biomedica PLC
15 December 2005
Oxford BioMedica plc ('the Company')
Directors' Shareholdings
Following the completion of the Company's Placing, Open Offer and Subscription
which occurred today, the Company has today been notified by those Directors of
the Company whose respective holdings in ordinary shares of 1p in the Company
('Ordinary Shares') has increased as a result of taking up their entitlement to
Ordinary Shares under the Open Offer as follows:
Director Increase in Resultant % of issued
Ordinary Shares holdings of share capital
Ordinary Shares
P.J. Nolan 2,000 149,738 0.03
N.L. Woolf 11,000 165,000 0.03
P.N Rodgers 12,000 22,000 0.00
R.Uppal 1 11,000 165,000 0.03
1. These Ordinary Shares are held in a self-invested pension plan
15 December 2005
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.